BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3152809)

  • 1. CML: new biologic therapies, endpoints and questions.
    Martin A; Cheson BD
    Oncology (Williston Park); 1987 Sep; 1(7):12-3, 16. PubMed ID: 3152809
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of chronic myelogenous leukemia with interferons: hematologic, cellular, and genetic investigations.
    Opalka B; Kloke O; Wandl U; Becher R; Niederle N
    Haematol Blood Transfus; 1989; 32():134-8. PubMed ID: 2516494
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b.
    Freund M; von Wussow P; Knüver-Hopf J; Mohr H; Pohl U; Exeriede G; Link H; Wilke HJ; Poliwoda H
    Blut; 1988 Nov; 57(5):311-5. PubMed ID: 3196882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of chronic myeloid leukemia in chronic phase with interferons].
    Guilhot F
    Pathol Biol (Paris); 1988 Dec; 36(10):1179-81. PubMed ID: 3070457
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon alpha in the therapy of CML.
    Talpaz M; Kantarjian H; Kurzrock R; Gutterman JU
    Br J Haematol; 1991 Oct; 79 Suppl 1():38-41. PubMed ID: 1931707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined therapy interferon and chemotherapy in chronic myelogenous leukemia.
    Guilhot F; Dreyfus B; Desmarest MC; Giraud C; Huret JL; Brizard A; Tanzer J
    Nouv Rev Fr Hematol (1978); 1989; 31(2):171-3. PubMed ID: 2771633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation.
    Borgies P; Ferrant A; Delannoy A; Van den Berghe H; Michaux JL
    Bone Marrow Transplant; 1989 Jan; 4(1):127-8. PubMed ID: 2647178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha.
    Russo D; Fanin R; Zuffa E; Damiani D; Gallizia C; Michieli M; Testoni N; Benfenati D; Visani G; Zaccaria A
    Haematologica; 1990; 75(4):334-9. PubMed ID: 2125966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of alpha-interferons in chronic myelogenous leukaemia.
    Talpaz M
    Br J Clin Pract Suppl; 1988 Mar; 62():13-5. PubMed ID: 3145008
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer Center.
    Kantarjian HM; Talpaz M
    Leuk Lymphoma; 1993; 11 Suppl 1():169-74. PubMed ID: 8251891
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic prospects of interferon in patients with chronic myelocytic leukemia].
    Podsiadło Z; Skotnicki AB; Blicharski J
    Przegl Lek; 1988; 45(9):687-9. PubMed ID: 3075051
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic myelogenous leukemia: does interferon alpha prolong life?
    Hehlmann R
    Leukemia; 1996 Feb; 10(2):193-6. PubMed ID: 8637225
    [No Abstract]   [Full Text] [Related]  

  • 13. [The treatment of chronic myeloleukemia with recombinant alfa-2 interferon].
    Strozha I; Petukhov V; Bondare D; Feldmane G; Duks A; Teilane I; Medne I; Mauritsas M; Grinberga L
    Ter Arkh; 1993; 65(10):62-6. PubMed ID: 8296238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotherapy of chronic myelogenous leukemia with interferon.
    Ozer H
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):14-20. PubMed ID: 2461592
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon-alpha 2a therapy in CML: disappearance of BCR/ABL transcript in a case of long-lasting continuous cytogenetic conversion.
    Pardini S; Addis M; Dore F; Bonfigli S; Nieddu RM; Galanello R; Longinotti M; Pau MG
    Haematologica; 1994; 79(6):540-1. PubMed ID: 7896213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent suppression of granulo-erythropoietic precursor cells in alpha interferon treated CML patients undergoing autologous stem cell transplantation: in vitro and clinical results.
    De Fabritiis P; Sandrelli A; Meloni G; De Felice L; Di Matteo G; Alimena G; Montefusco E; Defazio D; Mandelli F
    Prog Clin Biol Res; 1990; 333():225-33. PubMed ID: 2308984
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of chronic myeloid leukemia with interferon].
    Fülle HH; Dahmen E; Hellriegel KP
    Onkologie; 1988 Aug; 11(4):177-83. PubMed ID: 3054669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of interferon-alfa (reaferon) in patients with chronic myeloleukemia].
    Machiulaĭtene ER; Lasunskaia EB; Nefedova IuB; Perekalina TA; Salogub GN; Poliakova LE
    Ter Arkh; 1996; 68(10):44-7. PubMed ID: 9026942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyclonal hematopoiesis in interferon-induced cytogenetic remissions of chronic myelogenous leukemia.
    Claxton D; Deisseroth A; Talpaz M; Reading C; Kantarjian H; Trujillo J; Stass S; Gooch G; Spitzer G
    Blood; 1992 Feb; 79(4):997-1002. PubMed ID: 1371081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukemia.
    Sawyers CL
    N Engl J Med; 1999 Apr; 340(17):1330-40. PubMed ID: 10219069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.